INDOCO Remedies Ltd Consolidated Q3 PAT Up At Rs. 9.10 Crore

INDOCO REMEDIES LTD. has reported financial results for the period ended December 31, 2019.

Financial Results (Q3 FY19-20) – QoQ Comparison

The company has reported net sales of Rs.290.07 crores during the period ended December 31, 2019 as compared to Rs.293.15 crores during the period ended September 30, 2019.

The company has posted net profit of Rs.9.10 crores for the period ended December 31, 2019 as against Rs.7.81 crores for the period ended September 30, 2019.

The company has reported EPS of Rs.0.99 for the period ended December 31, 2019 as compared to Rs.0.85 for the period ended September 30, 2019.

Financials	Q3 FY19-20	Q2 FY19-20	% Change
Total Income	₹ 290.07 crs	₹ 293.15 crs	-1.05%
Net Profit	₹ 9.10 crs	₹ 7.81 crs	16.52%
EPS	₹ 0.99	₹ 0.85	16.47%

Financial Results (Q3 FY19-20) – YoY Comparison

The company has reported net sales of Rs.290.07 crores during the period ended December 31, 2019 as compared to Rs.263.20 crores during the period ended December 31, 2018.

The company has posted net profit of Rs.9.10 crores for the period ended December 31, 2019 as against Rs.5.27 crores for the period ended December 31, 2018.

The company has reported EPS of Rs.0.99 for the period ended December 31, 2019 as compared to Rs.0.57 for the period ended December 31, 2018.

Financials	Q3 FY19-20	Q3 FY18-19	% Change
Total Income	₹ 290.07 crs	₹ 263.20 crs	10.21%
Net Profit	₹ 9.10 crs	₹ 5.27 crs	72.68%
EPS	₹ 0.99	₹ 0.57	73.68%

Financial Results (9 months ended FY 19-20) – YoY Comparison

The company has reported net sales of Rs.836.54 crores during the 9 months period ended December 31, 2019 as compared to Rs.717.61 crores during the 9 months period ended December 31, 2018.

The company has posted net profit of Rs.18.73 crores for the 9 months period ended December 31, 2019 as against net loss of Rs.(14.38) crores for the 9 months period ended December 31, 2018.

The company has reported EPS of Rs.2.04 for the 9 months period ended December 31, 2019 as compared to Rs.(1.56) for the 9 months period ended December 31, 2018.

Financials	9 months FY19-20	9 months FY18-19	% Change
Total Income	₹ 836.54 crs	₹ 717.61 crs	16.57%
Net Profit	₹ 18.73 crs	₹ (14.38) crs	230.25%
EPS	₹ 2.04	₹(1.56)	230.77%

Commenting on the third quarter results, Aditi Panandikar, Managing Director, Indoco Remedies Ltd., said, “During the third quarter, India Business continued the growth momentum by clocking a growth of 17%.

International business registered a growth of 21% in the third quarter. Considering the planned product launches in US, we expect the growth momentum in International business to continue”.

Shares of INDOCO REMEDIES LTD. was last trading in BSE at Rs.227.55 as compared to the previous close of Rs. 229.6. The total number of shares traded during the day was 15140 in over 942 trades.

The stock hit an intraday high of Rs. 233.6 and intraday low of 225.7. The net turnover during the day was Rs. 3465839.-Equity Bulls